Header Logo

Connection

AKIVA DIAMOND to Rituximab

Back to Details
This is a "connection" page, showing publications AKIVA DIAMOND has written about Rituximab.
AKIVA DIAMOND
Connection Strength
0.187
Rituximab
  1. Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis. Leukemia. 2023 07; 37(7):1558-1560.
    View in: PubMed
    Score: 0.187
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.